AURIGENE DISCOVERY TECHNOLOGIES LIMITED

During the FY19-20, Bengaluru-based Aurigene Discovery Technologies, a wholly-owned subsidiary of Dr. Reddy’s Laboratories Ltd., generated a revenue figure of Rs 280 crore, exhibiting a growth of 33 per cent in comparison to the revenue generation of Rs 211 crore during the FY18-19. The company announced its partnership with US-based firm Exelixis during the FY19-20, for bringing oncology therapies to market. Aurigene, engaged in the discovery and clinical development of novel and best-in-class therapies to treat cancer and inflammatory diseases, has partnered with many large and mid-pharma companies in the United States and Europe and has 15 programmes currently in clinical development.